Responsible for end-to-end site management and monitoring activities in Phase II–III clinical trials
Ensuring compliance with ICH-GCP, protocol requirements, and Novo Nordisk procedures
Serving as the primary liaison between Novo Nordisk, clinical sites, and study teams
Conducting on-site and remote monitoring visits to ensure protocol compliance
Managing sites across the trial lifecycle (selection, initiation, conduct and close-out)
Driving inspection readiness and high-quality documentation
Building strong, trusted partnerships with new and existing sites
Supporting patient recruitment and retention initiatives at site level
Using digital tools and systems effectively to plan, execute and document monitoring activities
Maintaining accurate trial documentation, including the Investigator Trial Master File, and ensuring inspection readiness throughout all trial stages

A Bachelor's degree in Life Sciences or a related field
At least 1 year of independent CRA experience in Phase II and Phase III clinical trials is mandatory
Previous experience in diabetes, obesity, CVD and / or rare diseases will be an advantage
Strong understanding and knowledge of ICH-GCP guidelines, regulatory requirements, and clinical trials methodology
Proficiency in digital tools, including electronic data capture (EDC) systems, CTMS, eTMF, and other clinical trial software
High level of English and Portuguese (written and spoken)

Clinical Research Associate

Key skills